In that analysis, each woman taking a GLP-1 drug was paired with a nonuser who shared similar characteristics, including age, race, ethnicity, BMI, breast density, and diabetes status
Monthly Progress Reviews Body composition tracking, lab review when appropriate, and protocol adjustments by our team
Zepbound also became the first prescription medication approved by the FDA to treat moderate-to-severe obstructive sleep apnea in adults with obesity, expanding its clinical use beyond weight management alone
Surprisingly, it was found that the Si-based agent not only relieved the intestinal symptoms associated with colitis but also the psychological symptoms such as visceral pain and discomfort
488 Octreotide, a somatostatin analog used to suppress pancreatic enzyme secretion, is capable of crossing the placental barrier
When in doubt, err on the side of seeking medical evaluation